{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:25:47Z","timestamp":1786116347017,"version":"build-2736575974"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>The use of intravenous thrombolysis (IVT) in acute ischemic stroke (AIS) patients with recent direct oral anticoagulant (DOAC) intake remains one of the most debated issues in contemporary stroke medicine. Current international guidelines generally discourage IVT within 48\u202fh of DOAC ingestion, largely because of concerns regarding symptomatic intracranial hemorrhage (sICH) and the absence of randomized evidence. However, an increasing body of evidence from international registries and multicenter cohorts has not identified a clear increase in sICH among carefully selected patients with recent DOAC exposure who received IVT. Some observational studies have also reported an association with more favorable functional outcomes than those observed in otherwise eligible patients in whom reperfusion therapy was withheld, although these comparisons are susceptible to selection bias and confounding by indication. In this Perspective, we discuss recent advances that have challenged the traditional practice of broadly excluding patients with recent DOAC exposure from IVT. We review observational evidence concerning IVT in selected patients, examine biological hypotheses that could be relevant to the observed clinical findings, and discuss evolving roles of reversal agents and laboratory assessment of anticoagulant activity. We further highlight current implementation barriers and future research priorities, including prospective studies, improved point-of-care anticoagulant testing, and refinement of patient-selection strategies. We argue that contemporary evidence supports reconsideration of rigid time-based exclusion criteria in favor of more individualized, evidence-informed decision-making. Although important uncertainties remain, recent DOAC exposure may not necessarily preclude IVT in appropriately selected patients, particularly when anticoagulant activity can be reliably assessed.<\/jats:p>","DOI":"10.3389\/fneur.2026.1904486","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T09:25:31Z","timestamp":1786008331000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Intravenous thrombolysis in acute ischemic stroke after recent direct oral anticoagulant intake: toward evidence-informed care"],"prefix":"10.3389","volume":"17","author":[{"given":"Matija","family":"Zupan","sequence":"first","affiliation":[{"name":"Department of Vascular Neurology, University Medical Centre Ljubljana","place":["Ljubljana, Slovenia"]},{"name":"Faculty of Medicine, University of Ljubljana","place":["Ljubljana, Slovenia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi\u0161o","family":"\u0160abovi\u010d","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Ljubljana","place":["Ljubljana, Slovenia"]},{"name":"Department of Vascular Disorders, University Medical Center Ljubljana","place":["Ljubljana, Slovenia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Kermer","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Medical Center G\u00f6ttingen","place":["G\u00f6ttingen, Germany"]},{"name":"Department of Neurology, Friesland Kliniken GmbH","place":["Sande, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senta","family":"Frol","sequence":"additional","affiliation":[{"name":"Department of Vascular Neurology, University Medical Centre Ljubljana","place":["Ljubljana, Slovenia"]},{"name":"Faculty of Medicine, University of Ljubljana","place":["Ljubljana, Slovenia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e044321","DOI":"10.1161\/JAHA.125.044321","article-title":"Intravenous thrombolysis in patients on direct oral anticoagulants: analysis of the get with the guidelines stroke registry","volume":"15","author":"Yaghi","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"I","DOI":"10.1177\/2396987321989865","article-title":"European stroke organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke","volume":"6","author":"Berge","year":"2021","journal-title":"Eur Stroke J"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e316","DOI":"10.1161\/STR.0000000000000513","article-title":"2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association\/American Stroke Association","volume":"57","author":"Prabhakaran","year":"2026","journal-title":"Stroke"},{"key":"ref4","year":"2026"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/ana.27189","article-title":"Intravenous thrombolysis in patients taking direct Oral anticoagulation treatment before stroke onset: results from the safe implementations of treatments in stroke international stroke registry","volume":"97","author":"Matusevicius","year":"2025","journal-title":"Ann Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1001\/jamaneurol.2022.4782","article-title":"Intravenous thrombolysis in patients with ischemic stroke and recent ingestion of direct oral anticoagulants","volume":"80","author":"Meinel","year":"2023","journal-title":"JAMA Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e218012","DOI":"10.1212\/WNL.0000000000218012","article-title":"Safety and outcomes of dabigatran reversal with Idarucizumab before IV thrombolysis in patients with acute ischemic stroke","volume":"106","author":"S\u00e4flund","year":"2026","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s42466-025-00438-4","article-title":"Recent intake of direct oral anticoagulants and acute ischemic stroke: real world data from a comprehensive stroke center","volume":"7","author":"Pommeranz","year":"2025","journal-title":"Neurol Res Pract"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s42466-025-00450-8","article-title":"Safety of tenecteplase versus alteplase for intravenous thrombolysis in acute ischemic stroke patients with direct oral anticoagulation: experience from a German stroke center","volume":"7","author":"Mers","year":"2025","journal-title":"Neurol Res Pract."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.11.019","article-title":"Intravenous thrombolysis after idarucizumab application in acute stroke patients-a potentially increased sensitivity of thrombi to lysis?","volume":"28","author":"Pretnar Oblak","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"8727","DOI":"10.3390\/ijms25168727","article-title":"Beyond anticoagulation: a comprehensive review of non-vitamin K oral anticoagulants (NOACs) in inflammation and protease-activated receptor signaling","volume":"25","author":"Jannati","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s40256-020-00438-6","article-title":"Potential therapeutic roles for direct factor Xa inhibitors in coronavirus infections","volume":"20","author":"Al-Horani","year":"2020","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"666086","DOI":"10.3389\/fneur.2021.666086","article-title":"Intravenous thrombolysis after dabigatran reversal by Idarucizumab: a systematic review of the literature","volume":"12","author":"Frol","year":"2021","journal-title":"Front Neurol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1177\/1747493019895654","article-title":"Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany-updated series of 120 cases","volume":"15","author":"Kermer","year":"2020","journal-title":"Int J Stroke"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"5920","DOI":"10.1038\/s41598-021-85318-y","article-title":"The in vitro addition of idarucizumab to plasma samples from patients increases thrombin generation","volume":"11","author":"Bo\u017ei\u010d Mijovski","year":"2021","journal-title":"Sci Rep"},{"key":"ref16","year":"2025"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"P2628","DOI":"10.1177\/23969873251345751","article-title":"Thrombolysis with tenecteplase in acute ischemic stroke patients taking direct oral anticoagulants (PASSION): a multicenter randomized placebo-controlled clinical trial","volume":"10","author":"Schlemm","year":"2025","journal-title":"Eur Stroke J"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1904486\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T09:25:32Z","timestamp":1786008332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1904486\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":17,"alternative-id":["10.3389\/fneur.2026.1904486"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1904486","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"article-number":"1904486"}}